APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Induced Constipation (OIC) Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Opioid Induced Constipation (OIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchOpioid Induced Constipation (OIC) Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Induced Constipation (OIC) Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Opioid Induced Constipation (OIC) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Induced Constipation (OIC) Drugs Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Induced Constipation (OIC) Drugs Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Opioid Induced Constipation (OIC) Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Opioid Induced Constipation (OIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Induced Constipation (OIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Induced Constipation (OIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Opioid Induced Constipation (OIC) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Opioid Induced Constipation (OIC) Drugs include Takeda Pharmaceutical Company Limited, Pfizer, Theravance Biopharma Inc, Sucampo Pharmaceuticals, Shionogi & Co., Ltd, S.L.A. Pharma AG, Purdue Pharma, Progenics Pharmaceuticals Inc and Ono Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Induced Constipation (OIC) Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Induced Constipation (OIC) Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Induced Constipation (OIC) Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Induced Constipation (OIC) Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Induced Constipation (OIC) Drugs Segment by Company

Takeda Pharmaceutical Company Limited

Pfizer

Theravance Biopharma Inc

Sucampo Pharmaceuticals

Shionogi & Co., Ltd

S.L.A. Pharma AG

Purdue Pharma

Progenics Pharmaceuticals Inc

Ono Pharmaceutical Co., Ltd

Nektar Therapeutics

Mundipharma International Limited

Ironwood Pharmaceuticals Inc

Daiichi Sankyo Co Ltd

Daewoong Pharmaceutical

Cosmo Pharmaceuticals SA

C.B. Fleet Company

Bausch Health

Allergan Plc

Opioid Induced Constipation (OIC) Drugs Segment by Type

Alvimopan

Methyl Naltrexone Bromide

Lubiprostone

Naldemedine

Others

Opioid Induced Constipation (OIC) Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Opioid Induced Constipation (OIC) Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Induced Constipation (OIC) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Induced Constipation (OIC) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Induced Constipation (OIC) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Induced Constipation (OIC) Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Opioid Induced Constipation (OIC) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Opioid Induced Constipation (OIC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Opioid Induced Constipation (OIC) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Opioid Induced Constipation (OIC) Drugs Industry Trends Table 2. Opioid Induced Constipation (OIC) Drugs Industry Drivers Table 3. Opioid Induced Constipation (OIC) Drugs Industry Opportunities and Challenges Table 4. Opioid Induced Constipation (OIC) Drugs Industry Restraints Table 5. Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers Table 9. Global Opioid Induced Constipation (OIC) Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Opioid Induced Constipation (OIC) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Opioid Induced Constipation (OIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Opioid Induced Constipation (OIC) Drugs Manufacturers, Product Type & Application Table 13. Global Opioid Induced Constipation (OIC) Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Induced Constipation (OIC) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Alvimopan Table 17. Major Manufacturers of Methyl Naltrexone Bromide Table 18. Major Manufacturers of Lubiprostone Table 19. Major Manufacturers of Naldemedine Table 20. Major Manufacturers of Others Table 21. Global Opioid Induced Constipation (OIC) Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2021-2026) Table 25. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2027-2032) Table 26. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Retail Pharmacies Table 32. Major Manufacturers of Online Pharmacies Table 33. Major Manufacturers of Hospital Pharmacies Table 34. Global Opioid Induced Constipation (OIC) Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2021-2026) & (K Units) Table 36. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2027-2032) & (K Units) Table 37. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2021-2026) Table 38. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2027-2032) Table 39. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2021-2026) & (K Units) Table 41. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2027-2032) & (K Units) Table 42. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2021-2026) Table 43. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2027-2032) Table 44. Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2021-2026) Table 47. Global Opioid Induced Constipation (OIC) Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Opioid Induced Constipation (OIC) Drugs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2026) & (K Units) Table 51. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2027-2032) & (K Units) Table 52. Europe Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2026) & (K Units) Table 54. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2027-2032) & (K Units) Table 61. Global Opioid Induced Constipation (OIC) Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2021-2026) Table 65. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2027-2032) Table 66. Takeda Pharmaceutical Company Limited Company Information Table 67. Takeda Pharmaceutical Company Limited Business Overview Table 68. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 70. Takeda Pharmaceutical Company Limited Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Pfizer Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 75. Pfizer Recent Development Table 76. Theravance Biopharma Inc Company Information Table 77. Theravance Biopharma Inc Business Overview Table 78. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 80. Theravance Biopharma Inc Recent Development Table 81. Sucampo Pharmaceuticals Company Information Table 82. Sucampo Pharmaceuticals Business Overview Table 83. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 85. Sucampo Pharmaceuticals Recent Development Table 86. Shionogi & Co., Ltd Company Information Table 87. Shionogi & Co., Ltd Business Overview Table 88. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 90. Shionogi & Co., Ltd Recent Development Table 91. S.L.A. Pharma AG Company Information Table 92. S.L.A. Pharma AG Business Overview Table 93. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 95. S.L.A. Pharma AG Recent Development Table 96. Purdue Pharma Company Information Table 97. Purdue Pharma Business Overview Table 98. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 100. Purdue Pharma Recent Development Table 101. Progenics Pharmaceuticals Inc Company Information Table 102. Progenics Pharmaceuticals Inc Business Overview Table 103. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 105. Progenics Pharmaceuticals Inc Recent Development Table 106. Ono Pharmaceutical Co., Ltd Company Information Table 107. Ono Pharmaceutical Co., Ltd Business Overview Table 108. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 110. Ono Pharmaceutical Co., Ltd Recent Development Table 111. Nektar Therapeutics Company Information Table 112. Nektar Therapeutics Business Overview Table 113. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 115. Nektar Therapeutics Recent Development Table 116. Mundipharma International Limited Company Information Table 117. Mundipharma International Limited Business Overview Table 118. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 120. Mundipharma International Limited Recent Development Table 121. Ironwood Pharmaceuticals Inc Company Information Table 122. Ironwood Pharmaceuticals Inc Business Overview Table 123. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 125. Ironwood Pharmaceuticals Inc Recent Development Table 126. Daiichi Sankyo Co Ltd Company Information Table 127. Daiichi Sankyo Co Ltd Business Overview Table 128. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 130. Daiichi Sankyo Co Ltd Recent Development Table 131. Daewoong Pharmaceutical Company Information Table 132. Daewoong Pharmaceutical Business Overview Table 133. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 135. Daewoong Pharmaceutical Recent Development Table 136. Cosmo Pharmaceuticals SA Company Information Table 137. Cosmo Pharmaceuticals SA Business Overview Table 138. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 140. Cosmo Pharmaceuticals SA Recent Development Table 141. C.B. Fleet Company Company Information Table 142. C.B. Fleet Company Business Overview Table 143. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 145. C.B. Fleet Company Recent Development Table 146. Bausch Health Company Information Table 147. Bausch Health Business Overview Table 148. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Bausch Health Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 150. Bausch Health Recent Development Table 151. Allergan Plc Company Information Table 152. Allergan Plc Business Overview Table 153. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Portfolio Table 155. Allergan Plc Recent Development Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Opioid Induced Constipation (OIC) Drugs Distributors List Table 159. Opioid Induced Constipation (OIC) Drugs Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Opioid Induced Constipation (OIC) Drugs Product Image Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Induced Constipation (OIC) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Opioid Induced Constipation (OIC) Drugs Sales (2021-2032) & (K Units) Figure 5. Global Opioid Induced Constipation (OIC) Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Alvimopan Image Figure 9. Methyl Naltrexone Bromide Image Figure 10. Lubiprostone Image Figure 11. Naldemedine Image Figure 12. Others Image Figure 13. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2021-2032) Figure 19. Retail Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Hospital Pharmacies Image Figure 22. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2021-2032) Figure 25. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2021-2032) Figure 28. North America Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2021-2032) Figure 30. U.S. Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2021-2032) Figure 35. Germany Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2021-2032) Figure 42. China Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2021-2032) Figure 50. Brazil Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Opioid Induced Constipation (OIC) Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 61. North America Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Europe Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Opioid Induced Constipation (OIC) Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Opioid Induced Constipation (OIC) Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Alvimopan
  • Methyl Naltrexone Bromide
  • Lubiprostone
  • Naldemedine
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited
  • Pfizer
  • Theravance Biopharma Inc
  • Sucampo Pharmaceuticals
  • Shionogi & Co., Ltd
  • S.L.A. Pharma AG
  • Purdue Pharma
  • Progenics Pharmaceuticals Inc
  • Ono Pharmaceutical Co., Ltd
  • Nektar Therapeutics
  • Mundipharma International Limited
  • Ironwood Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Daewoong Pharmaceutical
  • Cosmo Pharmaceuticals SA
  • C.B. Fleet Company
  • Bausch Health
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Opioid Induced Constipation (OIC) Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Opioid Induced Constipation (OIC) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Opioid Induced Constipation (OIC) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Opioid Induced Constipation (OIC) Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Opioid Induced Constipation (OIC) Drugs Market Dynamics
  1. 2.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
  2. 2.2 Opioid Induced Constipation (OIC) Drugs Industry Drivers
  3. 2.3 Opioid Induced Constipation (OIC) Drugs Industry Opportunities and Challenges
  4. 2.4 Opioid Induced Constipation (OIC) Drugs Industry Restraints
3 Opioid Induced Constipation (OIC) Drugs Market by Manufacturers
  1. 3.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Opioid Induced Constipation (OIC) Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Opioid Induced Constipation (OIC) Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Opioid Induced Constipation (OIC) Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Opioid Induced Constipation (OIC) Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Opioid Induced Constipation (OIC) Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Opioid Induced Constipation (OIC) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Opioid Induced Constipation (OIC) Drugs Tier 1, Tier 2, and Tier 3
4 Opioid Induced Constipation (OIC) Drugs Market by Type
  1. 4.1 Opioid Induced Constipation (OIC) Drugs Type Introduction
  2. 4.1.1 Alvimopan
  3. 4.1.2 Methyl Naltrexone Bromide
  4. 4.1.3 Lubiprostone
  5. 4.1.4 Naldemedine
  6. 4.1.5 Others
  7. 4.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Type
  8. 4.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type
  12. 4.3.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2021-2032)
5 Opioid Induced Constipation (OIC) Drugs Market by Application
  1. 5.1 Opioid Induced Constipation (OIC) Drugs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Application
  6. 5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application
  10. 5.3.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2021-2032)
6 Global Opioid Induced Constipation (OIC) Drugs Sales by Region
  1. 6.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Opioid Induced Constipation (OIC) Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region
  1. 7.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region
  2. 7.1.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032)
  8. 7.2.2 North America Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Limited
  2. 8.1.1 Takeda Pharmaceutical Company Limited Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Limited Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Limited Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Opioid Induced Constipation (OIC) Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Theravance Biopharma Inc
  14. 8.3.1 Theravance Biopharma Inc Company Information
  15. 8.3.2 Theravance Biopharma Inc Business Overview
  16. 8.3.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
  18. 8.3.5 Theravance Biopharma Inc Recent Developments
  19. 8.4 Sucampo Pharmaceuticals
  20. 8.4.1 Sucampo Pharmaceuticals Company Information
  21. 8.4.2 Sucampo Pharmaceuticals Business Overview
  22. 8.4.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Portfolio
  24. 8.4.5 Sucampo Pharmaceuticals Recent Developments
  25. 8.5 Shionogi & Co., Ltd
  26. 8.5.1 Shionogi & Co., Ltd Company Information
  27. 8.5.2 Shionogi & Co., Ltd Business Overview
  28. 8.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
  30. 8.5.5 Shionogi & Co., Ltd Recent Developments
  31. 8.6 S.L.A. Pharma AG
  32. 8.6.1 S.L.A. Pharma AG Company Information
  33. 8.6.2 S.L.A. Pharma AG Business Overview
  34. 8.6.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Portfolio
  36. 8.6.5 S.L.A. Pharma AG Recent Developments
  37. 8.7 Purdue Pharma
  38. 8.7.1 Purdue Pharma Company Information
  39. 8.7.2 Purdue Pharma Business Overview
  40. 8.7.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Portfolio
  42. 8.7.5 Purdue Pharma Recent Developments
  43. 8.8 Progenics Pharmaceuticals Inc
  44. 8.8.1 Progenics Pharmaceuticals Inc Company Information
  45. 8.8.2 Progenics Pharmaceuticals Inc Business Overview
  46. 8.8.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
  48. 8.8.5 Progenics Pharmaceuticals Inc Recent Developments
  49. 8.9 Ono Pharmaceutical Co., Ltd
  50. 8.9.1 Ono Pharmaceutical Co., Ltd Company Information
  51. 8.9.2 Ono Pharmaceutical Co., Ltd Business Overview
  52. 8.9.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
  54. 8.9.5 Ono Pharmaceutical Co., Ltd Recent Developments
  55. 8.10 Nektar Therapeutics
  56. 8.10.1 Nektar Therapeutics Company Information
  57. 8.10.2 Nektar Therapeutics Business Overview
  58. 8.10.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Portfolio
  60. 8.10.5 Nektar Therapeutics Recent Developments
  61. 8.11 Mundipharma International Limited
  62. 8.11.1 Mundipharma International Limited Company Information
  63. 8.11.2 Mundipharma International Limited Business Overview
  64. 8.11.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Portfolio
  66. 8.11.5 Mundipharma International Limited Recent Developments
  67. 8.12 Ironwood Pharmaceuticals Inc
  68. 8.12.1 Ironwood Pharmaceuticals Inc Company Information
  69. 8.12.2 Ironwood Pharmaceuticals Inc Business Overview
  70. 8.12.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Portfolio
  72. 8.12.5 Ironwood Pharmaceuticals Inc Recent Developments
  73. 8.13 Daiichi Sankyo Co Ltd
  74. 8.13.1 Daiichi Sankyo Co Ltd Company Information
  75. 8.13.2 Daiichi Sankyo Co Ltd Business Overview
  76. 8.13.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Portfolio
  78. 8.13.5 Daiichi Sankyo Co Ltd Recent Developments
  79. 8.14 Daewoong Pharmaceutical
  80. 8.14.1 Daewoong Pharmaceutical Company Information
  81. 8.14.2 Daewoong Pharmaceutical Business Overview
  82. 8.14.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Portfolio
  84. 8.14.5 Daewoong Pharmaceutical Recent Developments
  85. 8.15 Cosmo Pharmaceuticals SA
  86. 8.15.1 Cosmo Pharmaceuticals SA Company Information
  87. 8.15.2 Cosmo Pharmaceuticals SA Business Overview
  88. 8.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Portfolio
  90. 8.15.5 Cosmo Pharmaceuticals SA Recent Developments
  91. 8.16 C.B. Fleet Company
  92. 8.16.1 C.B. Fleet Company Company Information
  93. 8.16.2 C.B. Fleet Company Business Overview
  94. 8.16.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Portfolio
  96. 8.16.5 C.B. Fleet Company Recent Developments
  97. 8.17 Bausch Health
  98. 8.17.1 Bausch Health Company Information
  99. 8.17.2 Bausch Health Business Overview
  100. 8.17.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Portfolio
  102. 8.17.5 Bausch Health Recent Developments
  103. 8.18 Allergan Plc
  104. 8.18.1 Allergan Plc Company Information
  105. 8.18.2 Allergan Plc Business Overview
  106. 8.18.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Portfolio
  108. 8.18.5 Allergan Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Induced Constipation (OIC) Drugs Value Chain Analysis
  2. 9.1.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Induced Constipation (OIC) Drugs Production Mode & Process
  6. 9.2 Opioid Induced Constipation (OIC) Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Induced Constipation (OIC) Drugs Distributors
  9. 9.2.3 Opioid Induced Constipation (OIC) Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst